Other headlinesSonoSite shows vascular products
Takeover talk drives Hologic stock
Wall Street is buzzing with rumors that Hologic is a takeover target. The rumors have helped drive share prices of the women’s health specialist from a year low of under $12 in early summer to nearly $18 this week. Best known in radiology circles for its digital mammography equipment, Hologic expanded into therapeutics and other women’s products two years ago through a merger with Cytec.
SonoSite shows vascular products
The pioneer of handheld ultrasound is extending its reach in point-of-care medicine with technologies that address patient safety and mobile power for its vascular access ultrasound tools. Bothell, WA-based SonoSite showcased the enhancements at its booth Sept. 14 to 18 during the Association for Vascular Access (AVA) meeting in Las Vegas. Headlining the vascular exhibits are the company’s six-pound NanoMaxx, which is pending FDA clearance, a hand-carried unit that combines one-button operation with a fluid resistant touch screen user interface; LumenVu Catheter Guidance System, which is designed to visualize the placement of peripherally inserted central catheters at the point-of-care; and universal stands that charge batteries onboard SonoSite’s M-Turbo, S Series, NanoMaxx and MicroMaxx product, when the hand-carried systems are docked to the stands.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.